Watchlist Price Alert

Zosano Pharma Corporation (ZSAN)

NASDAQ: ZSAN · Real-Time Price · USD

0.56

0.00 (0.43%)

At close: Apr 24, 2025, 3:47 PM

Zosano Pharma Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Cash & Equivalents	13.53M	11.04M	17.15M	22.06M	26.88M	35.26M	43.55M	10.55M	18.56M	6.32M	6.49M	14.25M	6.14M	9.14M	11.96M	16.2M	3.54M	11.65M	13.29M	21.16M	37.34M	15M	19.18M	10.06M	6.56M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3.49M	4.9M	13.86M	17.51M	21.44M	n/a	n/a	6.56M	7.07M	n/a	n/a	3.88M	12.84M	21.81M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	455K	455K	455K	455K	458K	458K	458K	458K	458K	458K	476K	472K	476K	504K	690K	587K	455K	455K	455K	455K	175K	175K	423K	419K	408K
Receivables	107K	146K	196K	358K	243K	124K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	29K	54K	73K
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	2M	420K	787K	1.43M	1.35M	329K	615K	699K	623K	497K	779K	991K	921K	358K	1.07M	869K	1.97M	1.74M	1.33M	1.17M	762K	273K	412K	581K	1.46M
Total Current Assets	15.63M	11.61M	18.13M	23.84M	28.47M	35.72M	44.17M	11.25M	19.18M	6.81M	7.27M	18.73M	11.96M	23.36M	30.55M	38.51M	5.51M	13.39M	21.18M	29.39M	38.1M	15.28M	23.5M	23.53M	29.9M
Property-Plant & Equipment	10.36M	36.33M	36.41M	36.55M	36.78M	35.84M	35.83M	36.01M	35.7M	30.4M	28.92M	26.58M	23.09M	11.92M	7.62M	6.13M	4.41M	4.15M	4.24M	4.8M	4.9M	5.46M	6.11M	6.71M	7.24M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	10.81M	36.78M	36.87M	37.01M	37.24M	36.3M	36.28M	36.47M	36.16M	30.86M	29.4M	27.06M	23.56M	12.42M	8.31M	6.72M	4.87M	4.61M	4.7M	5.25M	5.08M	5.63M	6.53M	7.13M	7.65M
Total Assets	26.45M	48.39M	54.99M	60.85M	65.71M	72.01M	80.45M	47.71M	55.34M	37.67M	36.67M	45.79M	35.52M	35.78M	38.85M	45.23M	10.37M	18M	25.88M	34.64M	43.18M	20.91M	30.03M	30.66M	37.55M
Account Payables	3.72M	2.12M	1.55M	1.68M	2.66M	1.88M	1.97M	4.81M	3.26M	4.36M	3.81M	5.99M	3.68M	4.45M	1.21M	2.39M	2.42M	1.51M	1.07M	1.21M	907K	1.45M	1.69M	887K	1.4M
Deferred Revenue	n/a	26K	47K	226K	47K	n/a	n/a	16K	42K	27K	30K	20K	50K	187K	n/a	62K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	3.38M	5.43M	6.08M	6.32M	7.55M	6.97M	5.83M	5.04M	5.85M	5.71M	5.01M	4.17M	3.44M	2.33M	1.34M	3.6M	5.16M	6.69M	6.23M	6.12M	6.11M	5.99M	5.93M	6.25M	4.79M
Other Current Liabilities	2.63M	3.56M	3.96M	3.19M	4.15M	5.66M	5.38M	6.68M	11.45M	6.14M	5.27M	5.12M	8M	4.32M	3.12M	2.17M	3.09M	2.26M	2.07M	1.72M	2.54M	2.38M	2.25M	1.78M	2.04M
Total Current Liabilities	9.73M	11.13M	11.64M	11.41M	14.41M	14.51M	13.17M	16.55M	20.61M	16.24M	14.13M	15.29M	15.16M	11.29M	5.66M	8.23M	10.68M	10.46M	9.38M	9.04M	9.56M	9.82M	9.87M	8.92M	8.23M
Long-Term Debt	2.66M	4.05M	4.93M	6.15M	7.93M	9.86M	11.92M	12.69M	10.75M	12.04M	5.91M	5.09M	4.04M	4.48M	3.27M	n/a	n/a	n/a	1.95M	3.52M	5.05M	6.55M	8.1M	9.11M	10.52M
Other Long-Term Liabilities	n/a	231K	226K	221K	217K	127K	113K	8K	10K	n/a	6.26M	6.39M	6.67M	1.3M	1.43M	918K	716K	495K	323K	127K	52K	52K	51K	51K	50K
Total Long-Term Liabilities	2.66M	4.28M	5.15M	6.37M	8.15M	9.98M	12.03M	12.7M	10.76M	12.04M	12.16M	11.48M	10.71M	5.78M	4.69M	918K	716K	495K	2.27M	3.64M	5.1M	6.6M	8.15M	9.16M	10.57M
Total Liabilities	12.39M	15.41M	16.79M	17.78M	22.56M	24.5M	25.21M	29.25M	31.36M	28.28M	26.29M	26.78M	25.87M	17.07M	10.36M	9.15M	11.39M	10.95M	11.65M	12.69M	14.66M	16.42M	18.02M	18.08M	18.81M
Total Debt	6.04M	9.48M	11.01M	12.46M	15.49M	16.82M	17.75M	17.73M	16.6M	17.75M	10.92M	9.26M	7.48M	6.81M	4.6M	3.6M	5.16M	6.69M	8.18M	9.63M	11.15M	12.54M	14.03M	15.36M	15.31M
Common Stock	n/a	12K	12K	11K	11K	10K	10K	6K	5K	2K	2K	2K	1K	1K	1K	1K	n/a	n/a	4K	4K	4K	2K	2K	1K	1K
Retained Earnings	-395.52M	-362.12M	-355.14M	-346.48M	-340.33M	-332.19M	-324.09M	-315.4M	-307.51M	-298.82M	-289.88M	-280.02M	-270.66M	-261.23M	-251.09M	-242.92M	-234.08M	-225.87M	-218.38M	-210.51M	-203.77M	-196.77M	-188.97M	-181.53M	-175.01M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	-27.82M	-27.34M	-27.02M	n/a	n/a	n/a	1K	-5K	-26.18M	-25.95M	-25.77M	-25.61M	-26.31M	-2K	-25.07M	n/a	-1K	-2K	-7K
Shareholders Equity	14.05M	32.98M	38.2M	43.07M	43.15M	47.52M	55.24M	18.46M	23.97M	9.39M	10.38M	19.01M	9.65M	18.71M	28.5M	36.08M	-1.02M	7.05M	14.23M	21.96M	28.52M	4.49M	12.01M	12.58M	18.74M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3.49M	4.9M	13.86M	17.51M	21.44M	n/a	n/a	6.56M	7.07M	n/a	n/a	3.88M	12.84M	21.81M